See also this year's filing and all EDGAR filings for this company.
PDF Report 0001798749_2023_Aerovate_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001798749, Aerovate Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,496,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 242,000 |
| 3 | remainder_Assets | 3,563,000 |
| 4 | LiabilitiesCurrent | 7,782,000 |
| 5 | LiabilitiesNoncurrent | 705,000 |
| 6 | remainder_Liabilities | 71,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,615,000 |
| 9 | ResearchAndDevelopmentExpense | 38,622,000 |
| 10 | remainder_Expenses | 25,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,751,000 |
| 13 | remainder_ComprehensiveNetIncome | -407,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 135,301,000 |
| 1 | Liabilities | 8,558,000 |
| 2 | Expenses | 53,262,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 126,743,000 |
| 5 | NetIncome | -51,511,000 |
| 6 | ComprehensiveNetIncome | -51,714,500 |
| 7 | BaseVar | 99,639,500 |
| 8 | EconomicCapitalRatio | 2.31 |